VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

169 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 28 closing their positions.

Holders
169
Holders Change
-7
Holders Change %
-3.98%
% of All Funds
2.27%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
22
Increased
61
Reduced
64
Closed
28
Calls
$1.81M
Puts
$2.72M
Net Calls
-$912K
Net Calls Change
-$1.82M

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$24.4M
2
CC
2
Commodore Capital
New York
$68.2M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$40.5M
4
PBA
4
Paradigm Biocapital Advisors
New York
$38.3M
5
Citadel Advisors
5
Citadel Advisors
Florida
$9.08M

Top Sellers

1
DCM
1
Driehaus Capital Management
Illinois
$5.27M
2
GPP
2
Great Point Partners
Connecticut
$0
3
OCA
3
Octagon Capital Advisors
New York
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$12.6M
5
State Street
5
State Street
Massachusetts
$35.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$171M 12,238,803 +15,817 +0.1%
BlackRock
2
BlackRock
New York
$77.2M 5,521,035 -187,075 -3%
DTC
3
Deep Track Capital
Connecticut
$75.2M 5,380,449 – –
CC
4
Commodore Capital
New York
$68.2M 4,875,000 +1,275,000 +35%
Vanguard Group
5
Vanguard Group
Pennsylvania
$63M 4,508,508 -54,592 -1%
KCM
6
Kynam Capital Management
New Jersey
$61.9M 4,427,927 -272,073 -6%
VA
7
VR Adviser
New York
$54.3M 3,882,709 – –
FFM
8
Fairmount Funds Management
Pennsylvania
$48.4M 3,459,913 +14,100 +0.4%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$40.5M 2,895,265 +1,207,136 +72%
TCM
10
Tang Capital Management
California
$39.7M 2,842,925 +50,000 +2%
PBA
11
Paradigm Biocapital Advisors
New York
$38.3M 2,741,576 +646,497 +31%
State Street
12
State Street
Massachusetts
$35.7M 2,553,426 -312,074 -11%
NHAS
13
Novo Holdings A/S
Denmark
$33.3M 2,380,000 +129,700 +6%
MC
14
Maverick Capital
Texas
$31.6M 2,257,010 +195,736 +9%
AllianceBernstein
15
AllianceBernstein
Tennessee
$27.2M 1,944,020 -77,599 -4%
EP
16
Eversept Partners
New York
$26.6M 1,902,539 +524,865 +38%
BBA
17
Baker Bros. Advisors
New York
$24.4M 1,744,406 +1,744,406 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$24.3M 1,740,614 +20,089 +1%
Loomis, Sayles & Company
19
Loomis, Sayles & Company
Massachusetts
$18.7M 1,338,472 -31,884 -2%
PHP
20
Parkman Healthcare Partners
Connecticut
$18.2M 1,298,825 +234,319 +22%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$17.7M 1,265,754 +17,033 +1%
Marshall Wace
22
Marshall Wace
United Kingdom
$16.9M 1,207,871 +123,831 +11%
Adage Capital Partners
23
Adage Capital Partners
Massachusetts
$15.5M 1,108,586 -6,000 -0.5%
VC
24
Vivo Capital
California
$13.7M 982,576 – –
Goldman Sachs
25
Goldman Sachs
New York
$12.6M 899,825 -331,267 -27%
1
2 3 4 5